Top Markets
Coin of the day
Evofem Biosciences, Inc. Evofem Biosciences, Inc.

Evofem Biosciences, Inc.

EVFM
Rang in aandelen #38408
Evofem Biosciences, Inc. operates as a biopharmaceutical enterprise dedicated... Evofem Biosciences, Inc. operates as a biopharmaceutical enterprise dedicated to innovating and bringing to market treatments that address critical underserved areas in women's sexual and reproductive health. Their leading commercial offering is Phexxi, a vaginal gel specifically designed as a contraceptive. Additionally, the company is actively advancing EVO100, an antimicrobial vaginal gel under development, intended to prevent the urogenital spread of both Chlamydia trachomatis and Neisseria gonorrhoeae infections in women. The company's main office is situated in San Diego, California.
Aandeelprijs
$0.007524
Marktkapitalisatie
$997.16K
Verandering (1 dag)
-5.95%
Verandering (1 jaar)
-22.43%
Land
US
Handel Evofem Biosciences, Inc. (EVFM)

Categorie

Dividendrendementgeschiedenis voor Evofem Biosciences, Inc. (EVFM)
Het dividendrendement (TTM) van Evofem Biosciences, Inc. (aandelsymbool: EVFM) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Evofem Biosciences, Inc. (EVFM) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten